John Bencich, CFO at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), sold 1,380 shares at $0.57 ($787) on 2016-08-19, disclosed to the SEC on 2016-08-23.
Open-market sale of $787 OGXI by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.